Discontinued — last reported Q4 '25
Interest Paid
CSX Interest Paid remained flat by 0.0% to $217.50M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 2.4%, from $212.50M to $217.50M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 4.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
Detailed definition
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Peer comparison
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paidHistorical Data
| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $718.00M | $729.00M | $806.00M | $850.00M | $870.00M |
| YoY Change | — | +1.5% | +10.6% | +5.5% | +2.4% |
Interest Paid at Other Companies
Frequently Asked Questions
- What is CSX's interest paid?
- CSX (CSX) reported interest paid of $217.50M in Q4 2025.
- How has CSX's interest paid changed year-over-year?
- CSX's interest paid increased by 2.4% year-over-year, from $212.50M to $217.50M.
- What is the long-term trend for CSX's interest paid?
- Over 4 years (2021 to 2025), CSX's interest paid has grown at a 4.9% compound annual growth rate (CAGR), from $718.00M to $870.00M.
- What does interest paid mean?
- The actual cash paid to lenders for interest on debt.